Rapamycin NewsLatest News On Rapamycin Multiple myeloma mortality rates decline with advances in targeted therapies4/29/2026 6:36 PM UT San Antonio study evaluates rapamycin’s potential to promote healthy aging3/26/2026 1:28 AM Repurposed kidney drug finerenone shows promise in treating premature ovarian insufficiency3/5/2026 6:10 PM Barshop Institute at UT Health San Antonio secures major federal funding for longevity trial2/25/2026 3:23 AM ARPA-H-funded PROSPR program focuses on the biological hallmarks of aging2/25/2026 2:17 AM Milken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for sarcoidosis2/21/2026 4:21 AM Distinct gut toxicity patterns emerge with targeted cancer treatments2/21/2026 2:36 AM Case report examines potential cancer risks after mRNA vaccination2/12/2026 6:19 PM ICSA 2025: Infection's role in cellular senescence, inflammation, and aging1/8/2026 5:38 PM Engineered extracellular vesicles enable antigen-specific regulatory T cell induction12/23/2025 1:18 AM